Clinical Trial Update: Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating the efficacy of a combined PEV3A virosomal malaria vaccine and FP9-MVA ME-TRAP prime-boost regimen. The study, sponsored by t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria

Drugs mentioned

• FP9-MVA ME-TRAP Prime Boost Regimen
• PEV3A Virosomal Vaccine

Snippet

Sponsor: University of Oxford | Conditions: Malaria, Malaria, Falciparum | Phase 1, Phase 2 | Status: COMPLETED